Drug
Methylprednisolone (MP)
Methylprednisolone (MP) is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(20%)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_2
2
40%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(5)
Detailed Status
Not yet recruiting4
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 41 (20.0%)
N/A2 (40.0%)
Trials by Status
recruiting120%
not_yet_recruiting480%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingphase_2
Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
NCT07511582
recruitingphase_2
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
NCT03579875
not_yet_recruitingnot_applicable
Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome
NCT07328906
not_yet_recruitingnot_applicable
Methylprednisolone vs Dexamethasone: Effects on Sugammadex Reversal, Pain, and Nausea in Adults
NCT07187037
not_yet_recruitingphase_4
Methylprednisolone for Moderate to Severe Traumatic Brain Injury
NCT07180277
Clinical Trials (5)
Showing 5 of 5 trials
NCT07511582Phase 2
Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
NCT03579875Phase 2
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
NCT07328906Not Applicable
Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome
NCT07187037Not Applicable
Methylprednisolone vs Dexamethasone: Effects on Sugammadex Reversal, Pain, and Nausea in Adults
NCT07180277Phase 4
Methylprednisolone for Moderate to Severe Traumatic Brain Injury
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5